Genome Insight Launches in the U.S. with Innovative Whole Genome Sequencing Approach that Offers Unprecedented, Actionable Insights in Cancer Care
Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform